Cargando…
Cutaneous fungal microbiome: Malassezia yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial
Malassezia spp in skin microbiome scalp has been implicated in seborrheic dermatitis pathogenesis. Thus, treatment based in antifungal combined to topical keratolitic agents have been indicated as well as oral isotretinoin as it reduces the sebum production, glandular's size and possesses anti-...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821162/ https://www.ncbi.nlm.nih.gov/pubmed/29484095 http://dx.doi.org/10.1080/19381980.2017.1361573 |
_version_ | 1783301485242613760 |
---|---|
author | Kamamoto, C. S. L. Nishikaku, A. S. Gompertz, O. F. Melo, A. S. Hassun, K. M. Bagatin, E. |
author_facet | Kamamoto, C. S. L. Nishikaku, A. S. Gompertz, O. F. Melo, A. S. Hassun, K. M. Bagatin, E. |
author_sort | Kamamoto, C. S. L. |
collection | PubMed |
description | Malassezia spp in skin microbiome scalp has been implicated in seborrheic dermatitis pathogenesis. Thus, treatment based in antifungal combined to topical keratolitic agents have been indicated as well as oral isotretinoin as it reduces the sebum production, glandular's size and possesses anti-inflammatory properties. This randomized, comparative and therapeutic trial aimed toper form the genotypic identification of Malassezia species before and after low-dose oral isotretinoin or topical antifungal treatments for moderate to severe seborrhea and/or seborrheic dermatitis on scalp. Scales and sebum of the scalp were seeded in the middle of modified Dixon and incubated at 32°C. For genotypic identification polymerase chain reaction primers for the ITS and D1/D2 ribossomal DNA were used and followed by samples sequencing. The procedure was conducted before and after therapeutic and randomized intervention for moderate to severe seborrhea/seborrheic dermatitis on the scalp, including oral isotretinoin, 10 mg, every other day and anti-seborrheic shampoo (piroctone olamine), over six months. The M. globosa and M. restricta were the most frequent species isolated on the scalp before and after both treatments. Other non-Malassezia species were also identified. The Malassezia spp. were maintained in the scalp after both treatments that were equally effective for the control of seborrhea/seborrheic dermatitis clinical signs. |
format | Online Article Text |
id | pubmed-5821162 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-58211622018-02-26 Cutaneous fungal microbiome: Malassezia yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial Kamamoto, C. S. L. Nishikaku, A. S. Gompertz, O. F. Melo, A. S. Hassun, K. M. Bagatin, E. Dermatoendocrinol Research Paper Malassezia spp in skin microbiome scalp has been implicated in seborrheic dermatitis pathogenesis. Thus, treatment based in antifungal combined to topical keratolitic agents have been indicated as well as oral isotretinoin as it reduces the sebum production, glandular's size and possesses anti-inflammatory properties. This randomized, comparative and therapeutic trial aimed toper form the genotypic identification of Malassezia species before and after low-dose oral isotretinoin or topical antifungal treatments for moderate to severe seborrhea and/or seborrheic dermatitis on scalp. Scales and sebum of the scalp were seeded in the middle of modified Dixon and incubated at 32°C. For genotypic identification polymerase chain reaction primers for the ITS and D1/D2 ribossomal DNA were used and followed by samples sequencing. The procedure was conducted before and after therapeutic and randomized intervention for moderate to severe seborrhea/seborrheic dermatitis on the scalp, including oral isotretinoin, 10 mg, every other day and anti-seborrheic shampoo (piroctone olamine), over six months. The M. globosa and M. restricta were the most frequent species isolated on the scalp before and after both treatments. Other non-Malassezia species were also identified. The Malassezia spp. were maintained in the scalp after both treatments that were equally effective for the control of seborrhea/seborrheic dermatitis clinical signs. Taylor & Francis 2017-10-23 /pmc/articles/PMC5821162/ /pubmed/29484095 http://dx.doi.org/10.1080/19381980.2017.1361573 Text en © 2018 The Author(s). Published with license by Taylor & Francis http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Research Paper Kamamoto, C. S. L. Nishikaku, A. S. Gompertz, O. F. Melo, A. S. Hassun, K. M. Bagatin, E. Cutaneous fungal microbiome: Malassezia yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial |
title | Cutaneous fungal microbiome: Malassezia yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial |
title_full | Cutaneous fungal microbiome: Malassezia yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial |
title_fullStr | Cutaneous fungal microbiome: Malassezia yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial |
title_full_unstemmed | Cutaneous fungal microbiome: Malassezia yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial |
title_short | Cutaneous fungal microbiome: Malassezia yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial |
title_sort | cutaneous fungal microbiome: malassezia yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821162/ https://www.ncbi.nlm.nih.gov/pubmed/29484095 http://dx.doi.org/10.1080/19381980.2017.1361573 |
work_keys_str_mv | AT kamamotocsl cutaneousfungalmicrobiomemalasseziayeastsinseborrheicdermatitisscalpinarandomizedcomparativeandtherapeutictrial AT nishikakuas cutaneousfungalmicrobiomemalasseziayeastsinseborrheicdermatitisscalpinarandomizedcomparativeandtherapeutictrial AT gompertzof cutaneousfungalmicrobiomemalasseziayeastsinseborrheicdermatitisscalpinarandomizedcomparativeandtherapeutictrial AT meloas cutaneousfungalmicrobiomemalasseziayeastsinseborrheicdermatitisscalpinarandomizedcomparativeandtherapeutictrial AT hassunkm cutaneousfungalmicrobiomemalasseziayeastsinseborrheicdermatitisscalpinarandomizedcomparativeandtherapeutictrial AT bagatine cutaneousfungalmicrobiomemalasseziayeastsinseborrheicdermatitisscalpinarandomizedcomparativeandtherapeutictrial |